Aman U. Buzdar, M.D., is professor of medicine at the University of Texas Cancer Center at M.D. Anderson Hospital and Tumor Institute in Houston. He is also deputy department chairman in the department of breast medical oncology there, and an associate editor of the journal Clinical Cancer Research. His research interest lies in improving and defining short- and long-term benefits of chemotherapy, and he is testing several new hormonal therapies in the treatment of breast cancer. Dr. Buzdar was born in Pakistan and maintains many ties there, as indicated by his lifetime achievement award from the Pakistan Society of Clinical Oncology.
"I am thrilled to be able to join my international colleagues in reaching even more women around the world with the best information and guidance on breast cancer," he says of his position on the Breastcancer.org Professional Advisory Board.
Can we help guide you?
Create a profile for better recommendations
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...